We are accredited under Phase Three of the Recovery Loan Scheme – find out more here.


Mark Gardiner
Portfolio Executive

“The funding from FW Capital has enabled us to increase our laboratory capacity and turn test data around even more quickly for the new clients we’re attracting globally. We’ve also increased our R&D space, allowing us to launch new tests and develop more predictive models.”

Dr Carol Treasure, Managing Director

Founded in 2008, XCellR8 has a clear mission to accelerate the world’s transition to animal-free testing. It provides entirely animal-free safety and efficacy tests to the cosmetics, personal care and chemical industries and is the only laboratory internationally to have achieved regulatory recognition for animal-free adaptations of regulatory tests that have not only eliminated the use of animals, but animal-derived components too.

A £150,000 investment from NPIF – FW Capital Debt Finance was provided to help fund the company’s move to a new state-of-the-art laboratory on the Sci-Tech Daresbury National Science and Innovation Campus and bring in new world-class lab equipment and additional work stations.